Impact of intraprocedural antiplatelet therapy on stent patency and safety after emergent intracranial stenting in acute ischaemic stroke: insights from the RESISTANT registry.

Eur Stroke J · 2026 · PMC12964110 · PMID 41614535

Europe PMC DOI

hedged sentences

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

showed a trendP = .053so close (0.05 < p ≤ 0.1)

did not reach statistical significanceno p-value reported

Intravenous agents (Cangrelor/GPi) showed a trend towards lower risk of intraprocedural stent occlusion compared to oral dAPT (adjusted odds ratio [aOR] 0.30, [95% CI, 0.09–1.01], P = .053), though this did not reach statistical significance.

also in 33,481 other papers

a clear trendno p-value reported

In our cohort, intraprocedural stent occlusion occurred in over 11% of cases and was associated with a clear trend towards worse functional outcomes (33.3% vs 42.2%), and higher rates of sICH (12.2% vs 7.9%).

also in 12,254 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.